In this video, Yasha S. Modi, MD, discusses end-of-study results for EYP-1901 from EyePoint Pharmaceuticals, a bioerodible, sustained-release intravitreal insert to deliver vorolanib for diabetic ...

Three speakers outlined how AI is likely to have a major impact on the future of preventive cardiology.At the American ...

More than half of adults and more than one-third of children living in the same home as another adult with prediabetes have ...

LaShae D. Rolle, MPH, CPH, a national powerlifting champion, went to the gym to train less than 24 hours after receiving her ...

The FDA has approved Wegovy for the treatment of adults with noncirrhotic metabolic dysfunction-associated steatohepatitis ...

The American Academy of Orthopaedic Surgeons and the Musculoskeletal Tumor Society have developed a registry that aims to ...

When I attended Franklin & Marshall College in Lancaster, Pennsylvania, I was pre-med mainly for the fun of getting to say, ...

Treatment with CVN293 was well-tolerated among healthy adults, according to a poster presented at the Alzheimer’s Association ...

The field of cardiovascular disease prevention has made great strides in the 8 years since publication of the last U.S. blood ...

NCX 470 0.1%, a novel nitric oxide-donating bimatoprost eye drop, achieved its primary endpoint in the phase 3 Denali ...

Daily physical activity is effective in reducing risk for heart disease, but a dogmatic 10,000 steps per day goal is not ...

Wearing orthokeratology contact lenses for 11 years led to a substantial reduction in axial length, with a mean treatment ...